-
In the early days of large language models (LLMs), we grew accustomed to massive 10x jumps in reasoning and coding capability with every new model iteration. Today, those jumps have flattened into incremental gains. The exception is domain-specialized intelligence, where true step-function improvements are still the norm. When a model is fused with an organization’s…
-
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. There are more AI health tools than ever—but how well do they work? In the last few months alone, Microsoft, Amazon, and OpenAI have all launched medical chatbots. There’s a clear demand…
-
For decades, artificial intelligence has been evaluated through the question of whether machines outperform humans. From chess to advanced math, from coding to essay writing, the performance of AI models and applications is tested against that of individual humans completing tasks. This framing is seductive: An AI vs. human comparison on isolated problems with clear…
-
Earlier this month, Microsoft launched Copilot Health, a new space within its Copilot app where users will be able to connect their medical records and ask specific questions about their health. A couple of days earlier, Amazon had announced that Health AI, an LLM-based tool previously restricted to members of its One Medical service, would…
-
This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. Last Thursday, a California judge temporarily blocked the Pentagon from labeling Anthropic a supply chain risk and ordering government agencies to stop using its AI. It’s the latest development in the month-long…
-
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Inside the stealthy startup that pitched brainless human clones After operating in secrecy for years, R3 Bio, a California-based startup, suddenly revealed last week that it had raised money to create nonsentient monkey...
-
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
-
“Think of this as a human body,” says Javier González. In front of me is essentially a metal box on wheels. Standing at around a meter in height, it reminds me of a stainless-steel counter in a restaurant kitchen. It is covered in flexible plastic tubing—which act as veins and arteries—connecting a series of transparent…
-
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. How a couple of ski bums built the internet’s best weather app The best snow-forecasting app for skiers isn’t a federally-funded service or a big-name brand. It’s OpenSnow, a startup that uses government data,...
-
This week I reported on some rather unusual research that focuses on the brain of L. Stephen Coles. Coles was a gerontologist who died from pancreatic cancer in 2014. He had spent the latter part of his career specializing in human longevity. And before he died, he decided to have his brain preserved by a…